187 related articles for article (PubMed ID: 33544468)
21. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W
Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383
[TBL] [Abstract][Full Text] [Related]
22. LncRNA HOTAIR suppresses cell apoptosis, autophagy and induces cell proliferation in cholangiocarcinoma by modulating the miR-204-5p/HMGB1 axis.
Lu M; Qin X; Zhou Y; Li G; Liu Z; Yue H; Geng X
Biomed Pharmacother; 2020 Oct; 130():110566. PubMed ID: 32755793
[TBL] [Abstract][Full Text] [Related]
23. LncRNA LINC00668 promotes cell proliferation, migration, invasion ability and EMT process in hepatocellular carcinoma by targeting miR-532-5p/YY1 axis.
Xuan W; Zhou C; You G
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32249890
[TBL] [Abstract][Full Text] [Related]
24. AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8.
Jiang X; Li J; Wang W; Hu Z; Guan C; Zhao Y; Li W; Cui Y
Aging (Albany NY); 2020 Jan; 12(2):1237-1255. PubMed ID: 31978895
[TBL] [Abstract][Full Text] [Related]
25. YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to regulate LRRC1.
Guan C; Liu L; Zhao Y; Zhang X; Liu G; Wang H; Gao X; Zhong X; Jiang X
Aging (Albany NY); 2021 Dec; 13(23):25195-25212. PubMed ID: 34898474
[TBL] [Abstract][Full Text] [Related]
26. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y
Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma by negatively regulating the Wnt/β-catenin signaling pathway.
Hu X; Tan Z; Yang Y; Yang P
J Gene Med; 2019 May; 21(5):e3085. PubMed ID: 30856284
[TBL] [Abstract][Full Text] [Related]
28. LncRNA LINC00899 promotes progression of acute myeloid leukaemia by modulating miR-744-3p/YY1 signalling.
Dong X; Xu X; Guan Y
Cell Biochem Funct; 2020 Oct; 38(7):955-964. PubMed ID: 32157707
[TBL] [Abstract][Full Text] [Related]
29. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
31. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.
Zhang L; Jiang G; Lu J; Wang L
Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667
[TBL] [Abstract][Full Text] [Related]
32. miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells.
Liang F; Fu X; Wang L
J Cell Biochem; 2019 Oct; 120(10):18415-18424. PubMed ID: 31190375
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA PCAT1 regulates extrahepatic cholangiocarcinoma progression via the Wnt/β-catenin-signaling pathway.
Zhang F; Wan M; Xu Y; Li Z; Leng K; Kang P; Cui Y; Jiang X
Biomed Pharmacother; 2017 Oct; 94():55-62. PubMed ID: 28753454
[TBL] [Abstract][Full Text] [Related]
34. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.
Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y
Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691
[TBL] [Abstract][Full Text] [Related]
35. lncRNA TM4SF1-AS1 predicts dismal outcomes and promotes cholangiocarcinoma progression via modulating miR-744-3p.
Jiang H; Li W; Xue Z; Chen W; Zhao L; Song H; Hou J
Clin Res Hepatol Gastroenterol; 2022; 46(7):101915. PubMed ID: 35346892
[TBL] [Abstract][Full Text] [Related]
36. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion.
Zhou Z; Ma J
Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918
[TBL] [Abstract][Full Text] [Related]
37. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis.
Du H; Hou S; Zhang L; Liu C; Yu T; Zhang W
Aging (Albany NY); 2023 May; 15(9):3759-3770. PubMed ID: 37166421
[TBL] [Abstract][Full Text] [Related]
38. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis.
Sun ZP; Tan ZG; Peng C; Yi WM
J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226
[TBL] [Abstract][Full Text] [Related]
39. Upregulated microRNA-194 impairs stemness of cholangiocarcinoma cells through the Rho pathway via inhibition of ECT2.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2020 Oct; 121(10):4239-4250. PubMed ID: 31960990
[TBL] [Abstract][Full Text] [Related]
40. Transcription factor HIF1α promotes proliferation, migration, and invasion of cholangiocarcinoma via long noncoding RNA H19/microRNA-612/Bcl-2 axis.
Yu A; Zhao L; Kang Q; Li J; Chen K; Fu H
Transl Res; 2020 Oct; 224():26-39. PubMed ID: 32505707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
